Status:
UNKNOWN
To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Graves Disease
COVID-19
Eligibility:
All Genders
18-65 years
Brief Summary
The goal of this observational study is to learn about the correlation between COVID-19 and hyperthyroidism in Patients with hyperthyroidism complicated with COVID-19. The main questions it aims to an...
Detailed Description
Longitudinal analysis of GD status was performed: Three follow-up time points were identified: before COVID-19, three months and one year after recovering from COVID-19 (the first follow-up visit, the...
Eligibility Criteria
Inclusion
- According to the diagnostic criteria of hyperthyroidism in the Chinese Guidelines for the Diagnosis and Treatment of Thyroid Diseases formulated by the Chinese Society of Endocrinology of the Chinese Medical Association, the patient had been diagnosed with hyperthyroidism.
- In accordance with the diagnostic criteria of "The diagnosis and Treatment Protocol for novel coronavirus Infection (Trial version 10).
Exclusion
- Cases with incomplete data
- Patients with severe autoimmune diseases, hematological diseases and malignant tumors
- Immunodeficiency (e.g.AIDS, long-term use of corticosteroids or other immunosuppressive drugs leading to immunodeficiency)
- Follow-up was less than 30 days
- The results of thyroid function were less than 3 times
Key Trial Info
Start Date :
January 7 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 7 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06204393
Start Date
January 7 2023
End Date
August 7 2024
Last Update
May 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012